Number and order of whole cell pertussis vaccines in infancy and disease protection
To the Editor: I would like to report an incomplete financial disclosure related to a Viewpoint
published in JAMA. 1 While the topic of the Viewpoint was complementary and alternative
therapies, vaccine safety was mentioned. I did not understand then that conflicts of interest
related to vaccines needed to be reported. I would like to disclose that I am the co-inventor
and co-patent holder of the bovinehuman reassortant rotavirus vaccine Rotateq. My hospital
sold the patent more than 3 years ago, but I retained interest in the vaccine through the …
published in JAMA. 1 While the topic of the Viewpoint was complementary and alternative
therapies, vaccine safety was mentioned. I did not understand then that conflicts of interest
related to vaccines needed to be reported. I would like to disclose that I am the co-inventor
and co-patent holder of the bovinehuman reassortant rotavirus vaccine Rotateq. My hospital
sold the patent more than 3 years ago, but I retained interest in the vaccine through the …